Background: Micropapillary urothelial carcinoma (MPUC) is a rare variant of urothelial carcinoma (UC), which is often advanced at presentation, and carries poor prognosis. Majority of the reported cases of MPUC originate from the urinary bladder. Of over 190 MPUC cases reported in the English literature, 35 cases were of the upper urinary tract. We report a rare case of MPUC of the renal pelvis.
Case Report: A 73-year old woman presented with hematuria. She had a mass in the left renal pelvis with massive infiltration in the renal parenchyma. She underwent surgery. Pathological stage was pT4N2M1. Although she received chemotherapy, she died of disease 14 months after operation. Histologically, MPUC was found in 40% of the tumor, mostly in the infiltrating portion. Immunohistochemically, MPUC showed intracytoplasmic expression of CK7 and CK20. Distinctive expression of MUC1 was observed on the stroma-forming surface of the neoplastic clusters in MPUC. Positive staining for p53 and negative staining for bcl-2 were remarkable. In the review of the literature, overall male predominance was remarkable (M:F=5.09:1), but it was less pronounced in the upper urinary tract (M:F=1.61:1).
Conclusions: Here we present a rare case of MPUC arising in the renal pelvis with thorough review of the literature.
Download full-text PDF |
Source |
---|
J Pathol Clin Res
January 2025
Department of Urology, University of Duisburg-Essen, Essen, Germany.
Distinct molecular subtypes of muscle-invasive bladder cancer (MIBC) may show different platinum sensitivities. Currently available data were mostly generated at transcriptome level and have limited comparability to each other. We aimed to determine the platinum sensitivity of molecular subtypes by using the protein expression-based Lund Taxonomy.
View Article and Find Full Text PDFTransl Cancer Res
December 2024
Department of Urology, Affiliated Hospital of Chifeng University, Chifeng, China.
Background: Bladder urothelial carcinoma (BLCA) is globally recognized as a prevalent malignancy. Its treatment remains challenging due to the extensive morbidity, high mortality rates, and compromised quality of life from postoperative complications and the lack of specific molecular targets. Our aim was to establish a prognostic model to evaluate the prognostic significance, assess immunotherapy responses, and determine drug susceptibility in patients with BLCA.
View Article and Find Full Text PDFTransl Androl Urol
December 2024
Department of Urology, the First Hospital of Lanzhou University, Lanzhou, China.
Background: Bladder urothelial carcinoma (BLCA) is a highly heterogeneous cancer with a wide range of prognoses, ranging from low-grade non-muscle-invasive bladder cancer (NMIBC), which has a good prognosis but a high recurrence rate, to high-grade muscle-invasive bladder cancer (MIBC), which has a poor prognosis. Glycosylation dysregulation plays a significant role in cancer development. Therefore, this study aimed to investigate the role of glycosyltransferases (GT)-related genes in the prognosis of BLCA and to develop a prognostic model based on these genes to predict overall survival (OS) and assess its clinical application.
View Article and Find Full Text PDFTransl Androl Urol
December 2024
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Background: Transitional cell carcinoma (TCC) of the renal pelvis is a rare cancer within the urinary system. However, the prognosis is not entirely satisfactory. This study aims to develop a clinical model for predicting cancer-specific survival (CSS) at 1-, 3-, and 5-year for White Americans with renal pelvic TCC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!